Inflammatory Disease

All articles by Inflammatory Disease

Gilead, Tentarix collab to develop cancer, inflammatory disease therapies

Jack O'Brien

August 15, 2023

3:51 pm

Gilead has the option to acquire up to three selected Tentarix subsidiaries containing the programs developed through the partnership for $80 million per subsidiary.

From Our Partners

Partner Content

How data analytics and digital strategies accelerate health equity

Investing in and deploying digital technologies and data analytics capabilities is one of the most effective ways for health companies to gain better visibility into the health of patient populations.

Partner Content

Targeting in 2024: What brands need to know

With 2024 planning underway, now is the time to get strategic about audiences.

Partner Content

Rethinking TV advertising: Prioritizing privacy-safe custom audiences to increase conversion and improve outcomes

Generating elevated script lift through TV campaigns is possible with strategic targeting and delivery.

Partner Content

Rethinking the DTP media equation in cancer

Tools that help connect to hard-to-reach patient populations.

HAYMARKET MARKETING COMMUNICATIONS:

HAYMARKET MARKETING COMMUNICATIONS:

Quick Links

Inflammatory Disease

All articles by Inflammatory Disease

Gilead, Tentarix collab to develop cancer, inflammatory disease therapies

The MM+M Health Marketing Influencer 25

From Our Partners

Partner Content

How data analytics and digital strategies accelerate health equity

Partner Content

Targeting in 2024: What brands need to know

Partner Content

Rethinking TV advertising: Prioritizing privacy-safe custom audiences to increase conversion and improve outcomes

Partner Content

Rethinking the DTP media equation in cancer

Thank you for accessing MM+M.